カテゴリー： Market Monitor Global, 世界, 医療/バイオ

クローン病治療薬の世界市場見通し2023年-2029年

◆英語タイトル：Crohn’s Disease Drugs Market, Global Outlook and Forecast 2023-2029
	◆商品コード：MMG23LY8440 ◆発行会社（リサーチ会社）：Market Monitor Global ◆発行日：2023年7月 ◆ページ数：73 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後2-3営業日） ◆調査対象地域：グローバル ◆産業分野：医薬品＆ヘルスケア

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Crohn’s Disease Drugs Market 調査レポートは次の情報を含め、グローバルにおけるのクローン病治療薬市場規模と予測を収録しています。・世界のクローン病治療薬市場：売上、2018年-2023年、2024年-2029年
・世界のクローン病治療薬市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のクローン病治療薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「抗炎症剤」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

クローン病治療薬のグローバル主要企業は、Bayer AG、 Amgen、 Takeda Pharmaceutical、 AbbVie、 UCB、 Ferring、 Eli Lilly、 Hoffman-La Roche、 Bristol-Myers Squibb、 Pfizerなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、クローン病治療薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界のクローン病治療薬市場：タイプ別、2018年-2023年、2024年-2029年
世界のクローン病治療薬市場：タイプ別市場シェア、2022年
・抗炎症剤、免疫系抑制剤、抗生物質、その他

世界のクローン病治療薬市場：用途別、2018年-2023年、2024年-2029年
世界のクローン病治療薬市場：用途別市場シェア、2022年
・病院、診療所、病院薬局、小売薬局、オンライン薬局

世界のクローン病治療薬市場：地域・国別、2018年-2023年、2024年-2029年
世界のクローン病治療薬市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業におけるクローン病治療薬のグローバル売上、2018年-2023年
・主要企業におけるクローン病治療薬のグローバル売上シェア、2022年
・主要企業におけるクローン病治療薬のグローバル販売量、2018年-2023年
・主要企業におけるクローン病治療薬のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Bayer AG、 Amgen、 Takeda Pharmaceutical、 AbbVie、 UCB、 Ferring、 Eli Lilly、 Hoffman-La Roche、 Bristol-Myers Squibb、 Pfizer

*************************************************************

・調査・分析レポートの概要
クローン病治療薬市場の定義
市場セグメント
世界のクローン病治療薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のクローン病治療薬市場規模
世界のクローン病治療薬市場規模：2022年 VS 2029年
世界のクローン病治療薬市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのクローン病治療薬の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のクローン病治療薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：抗炎症剤、免疫系抑制剤、抗生物質、その他
クローン病治療薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、診療所、病院薬局、小売薬局、オンライン薬局
クローン病治療薬の用途別グローバル売上・予測

・地域別市場分析
地域別クローン病治療薬市場規模 2022年と2029年
地域別クローン病治療薬売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Bayer AG、 Amgen、 Takeda Pharmaceutical、 AbbVie、 UCB、 Ferring、 Eli Lilly、 Hoffman-La Roche、 Bristol-Myers Squibb、 Pfizer
...

Crohn’s disease (CD) is a form of inflammatory bowel disease (IBD), which is comprised of two chronic autoimmune diseases that cause intestinal inflammation: Crohn’s disease (CD) and ulcerative colitis (UC). The pathophysiology of CD is complex, as the disease is characterized by recurring flares that evolve along with periods of inactivity and remission.
This report aims to provide a comprehensive presentation of the global market for Crohn’s Disease Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Crohn’s Disease Drugs. This report contains market size and forecasts of Crohn’s Disease Drugs in global, including the following market information:
Global Crohn’s Disease Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Crohn’s Disease Drugs Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Crohn’s Disease Drugs companies in 2022 (%)
The global Crohn’s Disease Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Anti-Inflammatory Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Crohn’s Disease Drugs include Bayer AG, Amgen, Takeda Pharmaceutical, AbbVie, UCB, Ferring, Eli Lilly, Hoffman-La Roche and Bristol-Myers Squibb, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Crohn’s Disease Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Crohn’s Disease Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Crohn’s Disease Drugs Market Segment Percentages, by Type, 2022 (%)
Anti-Inflammatory
Immune system suppressors
Antibiotics
Others
Global Crohn’s Disease Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Crohn’s Disease Drugs Market Segment Percentages, by Application, 2022 (%)
Hospitals
Clinics
Hospitalshospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Crohn’s Disease Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Crohn’s Disease Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Crohn’s Disease Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Crohn’s Disease Drugs revenues share in global market, 2022 (%)
Key companies Crohn’s Disease Drugs sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Crohn’s Disease Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bayer AG
Amgen
Takeda Pharmaceutical
AbbVie
UCB
Ferring
Eli Lilly
Hoffman-La Roche
Bristol-Myers Squibb
Pfizer
Outline of Major Chapters:
Chapter 1: Introduces the definition of Crohn’s Disease Drugs, market overview.
Chapter 2: Global Crohn’s Disease Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Crohn’s Disease Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Crohn’s Disease Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Crohn’s Disease Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Crohn’s Disease Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Crohn’s Disease Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Crohn’s Disease Drugs Overall Market Size
2.1 Global Crohn’s Disease Drugs Market Size: 2022 VS 2029
2.2 Global Crohn’s Disease Drugs Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Crohn’s Disease Drugs Sales: 2018-2029
3 Company Landscape
3.1 Top Crohn’s Disease Drugs Players in Global Market
3.2 Top Global Crohn’s Disease Drugs Companies Ranked by Revenue
3.3 Global Crohn’s Disease Drugs Revenue by Companies
3.4 Global Crohn’s Disease Drugs Sales by Companies
3.5 Global Crohn’s Disease Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Crohn’s Disease Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Crohn’s Disease Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Crohn’s Disease Drugs Players in Global Market
3.8.1 List of Global Tier 1 Crohn’s Disease Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Crohn’s Disease Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Crohn’s Disease Drugs Market Size Markets, 2022 & 2029
4.1.2 Anti-Inflammatory
4.1.3 Immune system suppressors
4.1.4 Antibiotics
4.1.5 Others
4.2 By Type – Global Crohn’s Disease Drugs Revenue & Forecasts
4.2.1 By Type – Global Crohn’s Disease Drugs Revenue, 2018-2023
4.2.2 By Type – Global Crohn’s Disease Drugs Revenue, 2024-2029
4.2.3 By Type – Global Crohn’s Disease Drugs Revenue Market Share, 2018-2029
4.3 By Type – Global Crohn’s Disease Drugs Sales & Forecasts
4.3.1 By Type – Global Crohn’s Disease Drugs Sales, 2018-2023
4.3.2 By Type – Global Crohn’s Disease Drugs Sales, 2024-2029
4.3.3 By Type – Global Crohn’s Disease Drugs Sales Market Share, 2018-2029
4.4 By Type – Global Crohn’s Disease Drugs Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Crohn’s Disease Drugs Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Hospitalshospital Pharmacies
5.1.5 Retail Pharmacies
5.1.6 Online Pharmacies
5.2 By Application – Global Crohn’s Disease Drugs Revenue & Forecasts
5.2.1 By Application – Global Crohn’s Disease Drugs Revenue, 2018-2023
5.2.2 By Application – Global Crohn’s Disease Drugs Revenue, 2024-2029
5.2.3 By Application – Global Crohn’s Disease Drugs Revenue Market Share, 2018-2029
5.3 By Application – Global Crohn’s Disease Drugs Sales & Forecasts
5.3.1 By Application – Global Crohn’s Disease Drugs Sales, 2018-2023
5.3.2 By Application – Global Crohn’s Disease Drugs Sales, 2024-2029
5.3.3 By Application – Global Crohn’s Disease Drugs Sales Market Share, 2018-2029
5.4 By Application – Global Crohn’s Disease Drugs Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Crohn’s Disease Drugs Market Size, 2022 & 2029
6.2 By Region – Global Crohn’s Disease Drugs Revenue & Forecasts
6.2.1 By Region – Global Crohn’s Disease Drugs Revenue, 2018-2023
6.2.2 By Region – Global Crohn’s Disease Drugs Revenue, 2024-2029
6.2.3 By Region – Global Crohn’s Disease Drugs Revenue Market Share, 2018-2029
6.3 By Region – Global Crohn’s Disease Drugs Sales & Forecasts
6.3.1 By Region – Global Crohn’s Disease Drugs Sales, 2018-2023
6.3.2 By Region – Global Crohn’s Disease Drugs Sales, 2024-2029
6.3.3 By Region – Global Crohn’s Disease Drugs Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Crohn’s Disease Drugs Revenue, 2018-2029
6.4.2 By Country – North America Crohn’s Disease Drugs Sales, 2018-2029
6.4.3 US Crohn’s Disease Drugs Market Size, 2018-2029
6.4.4 Canada Crohn’s Disease Drugs Market Size, 2018-2029
6.4.5 Mexico Crohn’s Disease Drugs Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Crohn’s Disease Drugs Revenue, 2018-2029
6.5.2 By Country – Europe Crohn’s Disease Drugs Sales, 2018-2029
6.5.3 Germany Crohn’s Disease Drugs Market Size, 2018-2029
6.5.4 France Crohn’s Disease Drugs Market Size, 2018-2029
6.5.5 U.K. Crohn’s Disease Drugs Market Size, 2018-2029
6.5.6 Italy Crohn’s Disease Drugs Market Size, 2018-2029
6.5.7 Russia Crohn’s Disease Drugs Market Size, 2018-2029
6.5.8 Nordic Countries Crohn’s Disease Drugs Market Size, 2018-2029
6.5.9 Benelux Crohn’s Disease Drugs Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Crohn’s Disease Drugs Revenue, 2018-2029
6.6.2 By Region – Asia Crohn’s Disease Drugs Sales, 2018-2029
6.6.3 China Crohn’s Disease Drugs Market Size, 2018-2029
6.6.4 Japan Crohn’s Disease Drugs Market Size, 2018-2029
6.6.5 South Korea Crohn’s Disease Drugs Market Size, 2018-2029
6.6.6 Southeast Asia Crohn’s Disease Drugs Market Size, 2018-2029
6.6.7 India Crohn’s Disease Drugs Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Crohn’s Disease Drugs Revenue, 2018-2029
6.7.2 By Country – South America Crohn’s Disease Drugs Sales, 2018-2029
6.7.3 Brazil Crohn’s Disease Drugs Market Size, 2018-2029
6.7.4 Argentina Crohn’s Disease Drugs Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Crohn’s Disease Drugs Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Crohn’s Disease Drugs Sales, 2018-2029
6.8.3 Turkey Crohn’s Disease Drugs Market Size, 2018-2029
6.8.4 Israel Crohn’s Disease Drugs Market Size, 2018-2029
6.8.5 Saudi Arabia Crohn’s Disease Drugs Market Size, 2018-2029
6.8.6 UAE Crohn’s Disease Drugs Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Bayer AG
7.1.1 Bayer AG Company Summary
7.1.2 Bayer AG Business Overview
7.1.3 Bayer AG Crohn’s Disease Drugs Major Product Offerings
7.1.4 Bayer AG Crohn’s Disease Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Bayer AG Key News & Latest Developments
7.2 Amgen
7.2.1 Amgen Company Summary
7.2.2 Amgen Business Overview
7.2.3 Amgen Crohn’s Disease Drugs Major Product Offerings
7.2.4 Amgen Crohn’s Disease Drugs Sales and Revenue in Global (2018-2023)
7.2.5 Amgen Key News & Latest Developments
7.3 Takeda Pharmaceutical
7.3.1 Takeda Pharmaceutical Company Summary
7.3.2 Takeda Pharmaceutical Business Overview
7.3.3 Takeda Pharmaceutical Crohn’s Disease Drugs Major Product Offerings
7.3.4 Takeda Pharmaceutical Crohn’s Disease Drugs Sales and Revenue in Global (2018-2023)
7.3.5 Takeda Pharmaceutical Key News & Latest Developments
7.4 AbbVie
7.4.1 AbbVie Company Summary
7.4.2 AbbVie Business Overview
7.4.3 AbbVie Crohn’s Disease Drugs Major Product Offerings
7.4.4 AbbVie Crohn’s Disease Drugs Sales and Revenue in Global (2018-2023)
7.4.5 AbbVie Key News & Latest Developments
7.5 UCB
7.5.1 UCB Company Summary
7.5.2 UCB Business Overview
7.5.3 UCB Crohn’s Disease Drugs Major Product Offerings
7.5.4 UCB Crohn’s Disease Drugs Sales and Revenue in Global (2018-2023)
7.5.5 UCB Key News & Latest Developments
7.6 Ferring
7.6.1 Ferring Company Summary
7.6.2 Ferring Business Overview
7.6.3 Ferring Crohn’s Disease Drugs Major Product Offerings
7.6.4 Ferring Crohn’s Disease Drugs Sales and Revenue in Global (2018-2023)
7.6.5 Ferring Key News & Latest Developments
7.7 Eli Lilly
7.7.1 Eli Lilly Company Summary
7.7.2 Eli Lilly Business Overview
7.7.3 Eli Lilly Crohn’s Disease Drugs Major Product Offerings
7.7.4 Eli Lilly Crohn’s Disease Drugs Sales and Revenue in Global (2018-2023)
7.7.5 Eli Lilly Key News & Latest Developments
7.8 Hoffman-La Roche
7.8.1 Hoffman-La Roche Company Summary
7.8.2 Hoffman-La Roche Business Overview
7.8.3 Hoffman-La Roche Crohn’s Disease Drugs Major Product Offerings
7.8.4 Hoffman-La Roche Crohn’s Disease Drugs Sales and Revenue in Global (2018-2023)
7.8.5 Hoffman-La Roche Key News & Latest Developments
7.9 Bristol-Myers Squibb
7.9.1 Bristol-Myers Squibb Company Summary
7.9.2 Bristol-Myers Squibb Business Overview
7.9.3 Bristol-Myers Squibb Crohn’s Disease Drugs Major Product Offerings
7.9.4 Bristol-Myers Squibb Crohn’s Disease Drugs Sales and Revenue in Global (2018-2023)
7.9.5 Bristol-Myers Squibb Key News & Latest Developments
7.10 Pfizer
7.10.1 Pfizer Company Summary
7.10.2 Pfizer Business Overview
7.10.3 Pfizer Crohn’s Disease Drugs Major Product Offerings
7.10.4 Pfizer Crohn’s Disease Drugs Sales and Revenue in Global (2018-2023)
7.10.5 Pfizer Key News & Latest Developments
8 Global Crohn’s Disease Drugs Production Capacity, Analysis
8.1 Global Crohn’s Disease Drugs Production Capacity, 2018-2029
8.2 Crohn’s Disease Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Crohn’s Disease Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Crohn’s Disease Drugs Supply Chain Analysis
10.1 Crohn’s Disease Drugs Industry Value Chain
10.2 Crohn’s Disease Drugs Upstream Market
10.3 Crohn’s Disease Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Crohn’s Disease Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Crohn’s Disease Drugs in Global Market
Table 2. Top Crohn’s Disease Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Crohn’s Disease Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Crohn’s Disease Drugs Revenue Share by Companies, 2018-2023
Table 5. Global Crohn’s Disease Drugs Sales by Companies, (K Units), 2018-2023
Table 6. Global Crohn’s Disease Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Crohn’s Disease Drugs Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Crohn’s Disease Drugs Product Type
Table 9. List of Global Tier 1 Crohn’s Disease Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Crohn’s Disease Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Crohn’s Disease Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Crohn’s Disease Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Crohn’s Disease Drugs Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Crohn’s Disease Drugs Sales (K Units), 2018-2023
Table 15. By Type - Global Crohn’s Disease Drugs Sales (K Units), 2024-2029
Table 16. By Application – Global Crohn’s Disease Drugs Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Crohn’s Disease Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Crohn’s Disease Drugs Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Crohn’s Disease Drugs Sales (K Units), 2018-2023
Table 20. By Application - Global Crohn’s Disease Drugs Sales (K Units), 2024-2029
Table 21. By Region – Global Crohn’s Disease Drugs Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Crohn’s Disease Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Crohn’s Disease Drugs Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Crohn’s Disease Drugs Sales (K Units), 2018-2023
Table 25. By Region - Global Crohn’s Disease Drugs Sales (K Units), 2024-2029
Table 26. By Country - North America Crohn’s Disease Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Crohn’s Disease Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Crohn’s Disease Drugs Sales, (K Units), 2018-2023
Table 29. By Country - North America Crohn’s Disease Drugs Sales, (K Units), 2024-2029
Table 30. By Country - Europe Crohn’s Disease Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Crohn’s Disease Drugs Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Crohn’s Disease Drugs Sales, (K Units), 2018-2023
Table 33. By Country - Europe Crohn’s Disease Drugs Sales, (K Units), 2024-2029
Table 34. By Region - Asia Crohn’s Disease Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Crohn’s Disease Drugs Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Crohn’s Disease Drugs Sales, (K Units), 2018-2023
Table 37. By Region - Asia Crohn’s Disease Drugs Sales, (K Units), 2024-2029
Table 38. By Country - South America Crohn’s Disease Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Crohn’s Disease Drugs Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Crohn’s Disease Drugs Sales, (K Units), 2018-2023
Table 41. By Country - South America Crohn’s Disease Drugs Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Crohn’s Disease Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Crohn’s Disease Drugs Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Crohn’s Disease Drugs Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Crohn’s Disease Drugs Sales, (K Units), 2024-2029
Table 46. Bayer AG Company Summary
Table 47. Bayer AG Crohn’s Disease Drugs Product Offerings
Table 48. Bayer AG Crohn’s Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. Bayer AG Key News & Latest Developments
Table 50. Amgen Company Summary
Table 51. Amgen Crohn’s Disease Drugs Product Offerings
Table 52. Amgen Crohn’s Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. Amgen Key News & Latest Developments
Table 54. Takeda Pharmaceutical Company Summary
Table 55. Takeda Pharmaceutical Crohn’s Disease Drugs Product Offerings
Table 56. Takeda Pharmaceutical Crohn’s Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. Takeda Pharmaceutical Key News & Latest Developments
Table 58. AbbVie Company Summary
Table 59. AbbVie Crohn’s Disease Drugs Product Offerings
Table 60. AbbVie Crohn’s Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 61. AbbVie Key News & Latest Developments
Table 62. UCB Company Summary
Table 63. UCB Crohn’s Disease Drugs Product Offerings
Table 64. UCB Crohn’s Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 65. UCB Key News & Latest Developments
Table 66. Ferring Company Summary
Table 67. Ferring Crohn’s Disease Drugs Product Offerings
Table 68. Ferring Crohn’s Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 69. Ferring Key News & Latest Developments
Table 70. Eli Lilly Company Summary
Table 71. Eli Lilly Crohn’s Disease Drugs Product Offerings
Table 72. Eli Lilly Crohn’s Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 73. Eli Lilly Key News & Latest Developments
Table 74. Hoffman-La Roche Company Summary
Table 75. Hoffman-La Roche Crohn’s Disease Drugs Product Offerings
Table 76. Hoffman-La Roche Crohn’s Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 77. Hoffman-La Roche Key News & Latest Developments
Table 78. Bristol-Myers Squibb Company Summary
Table 79. Bristol-Myers Squibb Crohn’s Disease Drugs Product Offerings
Table 80. Bristol-Myers Squibb Crohn’s Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 81. Bristol-Myers Squibb Key News & Latest Developments
Table 82. Pfizer Company Summary
Table 83. Pfizer Crohn’s Disease Drugs Product Offerings
Table 84. Pfizer Crohn’s Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 85. Pfizer Key News & Latest Developments
Table 86. Crohn’s Disease Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 87. Global Crohn’s Disease Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 88. Global Crohn’s Disease Drugs Production by Region, 2018-2023 (K Units)
Table 89. Global Crohn’s Disease Drugs Production by Region, 2024-2029 (K Units)
Table 90. Crohn’s Disease Drugs Market Opportunities & Trends in Global Market
Table 91. Crohn’s Disease Drugs Market Drivers in Global Market
Table 92. Crohn’s Disease Drugs Market Restraints in Global Market
Table 93. Crohn’s Disease Drugs Raw Materials
Table 94. Crohn’s Disease Drugs Raw Materials Suppliers in Global Market
Table 95. Typical Crohn’s Disease Drugs Downstream
Table 96. Crohn’s Disease Drugs Downstream Clients in Global Market
Table 97. Crohn’s Disease Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Crohn’s Disease Drugs Segment by Type in 2022
Figure 2. Crohn’s Disease Drugs Segment by Application in 2022
Figure 3. Global Crohn’s Disease Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Crohn’s Disease Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Crohn’s Disease Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. Crohn’s Disease Drugs Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Crohn’s Disease Drugs Revenue in 2022
Figure 9. By Type - Global Crohn’s Disease Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Crohn’s Disease Drugs Revenue Market Share, 2018-2029
Figure 11. By Type - Global Crohn’s Disease Drugs Sales Market Share, 2018-2029
Figure 12. By Type - Global Crohn’s Disease Drugs Price (USD/Unit), 2018-2029
Figure 13. By Application - Global Crohn’s Disease Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Crohn’s Disease Drugs Revenue Market Share, 2018-2029
Figure 15. By Application - Global Crohn’s Disease Drugs Sales Market Share, 2018-2029
Figure 16. By Application - Global Crohn’s Disease Drugs Price (USD/Unit), 2018-2029
Figure 17. By Region - Global Crohn’s Disease Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Crohn’s Disease Drugs Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Crohn’s Disease Drugs Revenue Market Share, 2018-2029
Figure 20. By Region - Global Crohn’s Disease Drugs Sales Market Share, 2018-2029
Figure 21. By Country - North America Crohn’s Disease Drugs Revenue Market Share, 2018-2029
Figure 22. By Country - North America Crohn’s Disease Drugs Sales Market Share, 2018-2029
Figure 23. US Crohn’s Disease Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Crohn’s Disease Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Crohn’s Disease Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Crohn’s Disease Drugs Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Crohn’s Disease Drugs Sales Market Share, 2018-2029
Figure 28. Germany Crohn’s Disease Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. France Crohn’s Disease Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Crohn’s Disease Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Crohn’s Disease Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Crohn’s Disease Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Crohn’s Disease Drugs Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Crohn’s Disease Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Crohn’s Disease Drugs Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Crohn’s Disease Drugs Sales Market Share, 2018-2029
Figure 37. China Crohn’s Disease Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Crohn’s Disease Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Crohn’s Disease Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Crohn’s Disease Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. India Crohn’s Disease Drugs Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Crohn’s Disease Drugs Revenue Market Share, 2018-2029
Figure 43. By Country - South America Crohn’s Disease Drugs Sales Market Share, 2018-2029
Figure 44. Brazil Crohn’s Disease Drugs Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Crohn’s Disease Drugs Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Crohn’s Disease Drugs Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Crohn’s Disease Drugs Sales Market Share, 2018-2029
Figure 48. Turkey Crohn’s Disease Drugs Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Crohn’s Disease Drugs Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Crohn’s Disease Drugs Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Crohn’s Disease Drugs Revenue, (US$, Mn), 2018-2029
Figure 52. Global Crohn’s Disease Drugs Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Crohn’s Disease Drugs by Region, 2022 VS 2029
Figure 54. Crohn’s Disease Drugs Industry Value Chain
Figure 55. Marketing Channels

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ クローン病治療薬の世界市場見通し2023年-2029年(Crohn’s Disease Drugs Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

クローン病治療薬の世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp